Loading clinical trials...
Loading clinical trials...
Primarily, this clinical investigation compared the efficacy of cyclophosphamide + methotrexate + fluorouracil chemotherapy vs. goserelin + tamoxifen treatment in terms of prognosis (disease-free surv...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Austrian Breast & Colorectal Cancer Study Group
Collaborators
NCT06970912 · Hormone Receptor-Positive Breast Cancer, High-risk Breast Cancer, and more
NCT05559164 · Cardiac Toxicity, Early-stage Breast Cancer
NCT04553770 · Early-stage Breast Cancer, Hormone Receptor Positive Breast Carcinoma, and more
NCT05760612 · Early-stage Breast Cancer, HER2-positive Breast Cancer, and more
NCT05386719 · Breast Cancer, Early-stage Breast Cancer
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions